Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 34 medicinal chemistry PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


medicinal chemistry PhD Projects, Programmes & Scholarships

We have 34 medicinal chemistry PhD Projects, Programmes & Scholarships

More details

Science Research Opportunities at the University of East Anglia

The Faculty of Science is part of Norwich Research Park, one of Europe's leading research centres conducting cutting-edge multidisciplinary research with an annual research spend of over £130 million. Read more
 Funded PhD Programme (Students Worldwide)  PhD Opportunities
More details

New Platform Motifs for Reaction Discovery: Catalysis tools for sustainable synthesis

The introduction of new platform motifs enables the development of myriad new chemical transformations and enhanced understanding of reactivity. Read more
 Supervisor: Dr P Davies
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

Self-Funded PhD opportunity in Chemistry (Ref: SCI26-SF-005)

The Department of Chemistry has three core research themes, supported by major external funders (including UKRI, EU, Welcome Trust, Leverhulme Trust, Royal… Read more
 Supervisor: Dr P Goddard
 31 July 2026  PhD Research Project  Self-Funded PhD Students Only
More details

Deubiquitinase structure determination for developing novel therapeutics

Rational drug design relies on the availability of detailed structure information and the molecular properties of key binding sites that can be targeted by small molecular inhibitors or biologics. Read more
 Supervisor: Dr I Dreveny
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details
Last chance to apply

PhD Studentship in Chemical Biology – Developing Novel Treatments for Fungal Pathogens

Award summary. 100% home fees covered, a minimum tax-free annual living allowance of £20,780 (2025/26 UKRI rate) and a per annum budget of £6,000 for consumables and conference attendance etc. Read more
 Supervisors: Dr T McAllister, Prof P Race, Dr J Stach
 15 June 2026  PhD Research Project  Funded PhD Project (UK Students Only)
More details

Synthesis, Characterisation and Evaluation of Novel Antimicrobial Agents against Polymicrobial Biofilms.

Antimicrobial resistance (AMR) poses a major global health threat, driven in part by the persistence of polymicrobial biofilms that exhibit high tolerance to antimicrobial treatments and immune defences. Read more
 Supervisors: Dr A R Rahman, Dr L Cox
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

Tackling oxaliplatin drug resistance in colorectal cancer by developing a novel bifunctional prodrug

  Research Group: Institute of Cancer Therapeutics
Acquired drug resistance is a considerable problem for the treatment of colorectal cancer (CRC), of which oxaliplatin is a key component, with little improvement in the ~65% 5-year survival rate over the past 25 years. Read more
 Supervisors: Dr S Shnyder, Dr G Ribeiro Morais, Prof R Falconer
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents

  Research Group: Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases (polySTs). Read more
 Supervisors: Prof R Falconer, Dr S Shnyder
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

Developing novel treatments for invasive fungal infections

Invasive Fungal Infections. Invasive fungal infections, such as those caused by the fungi Candida, are an increasing global public health concern. Read more
 Supervisor: Dr FS Scott
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

PhD Studentship in Generative AI for Structure-Based De Novo Drug Design

De novo drug design seeks to generate novel drug-like molecules computationally, rather than identifying candidates from pre-existing chemical libraries. Read more
 Supervisor: Dr . Ballester
 3 July 2026  PhD Research Project  Funded PhD Project (Students Worldwide)
More details

Polysialyltransferases as a target in metastatic cancer

  Research Group: Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases. Read more
 Supervisors: Prof R Falconer, Dr S Shnyder
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

Development of chemical tools and bioactive compounds to explore the importance of enzyme activity in cancer diseases

Diversity-oriented synthesis (DOS) is a modern chemical methodology, which aims to synthesise small molecules that cover new chemical space with the possibility of finding unexplored biological targets or pathways that may be important for disease progression. Read more
 Supervisors: Prof K Pors, Dr V Jha, Dr Muhammad Wahajuddin
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

MSc by Research: Designing Molecular Glue Stabilizers to Restore Tumour Suppressor Function

Molecular glues, small molecules that facilitate the assembly of biomolecular complexes, have emerged as a transformative drug discovery strategy for treating diseases such as cancer and neurodegeneration. Read more
 Supervisor: Dr P Cossar
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

Accelerating the clinical introduction of novel antibiotic combinations effective against Gram-negative pathogens

Strathclyde Minor Groove Binders (S-MGB) lead compounds have in vivo activity (MIC 0.2 µg/mL) against Gram-positive bacteria.[1-5] In 2015 our commercial partner, MGB Biopharma, completed the successful Phase I Clinical Trial (NCT02518607) of our lead candidate MGB-BP-3 for the treatment of Clostridium difficile infections. Read more
 Supervisor: Dr FS Scott
 Year round applications  PhD Research Project  Self-Funded PhD Students Only
More details

PhD Studentship in Artificial Intelligence for Phenotypic Virtual Screening

Predictive models built with artificial intelligence (AI) are increasingly used to identify molecules with the potential to become effective therapies for cancer and other diseases. Read more
 Supervisor: Dr . Ballester
 10 July 2026  PhD Research Project  Funded PhD Project (Students Worldwide)

Filtering Results